| Tài liệu tham khảo |
Loại |
Chi tiết |
| [1] P. Pathak, M. J. Meziani, T. Desai, and Y.-P. Sun, “Formation and stabilization of ibuprofen nanoparticles in supercritical fluid processing,” J. Supercrit. Fluids, vol. 37, no.3, pp. 279–286, 2006 |
Sách, tạp chí |
| Tiêu đề: |
Formation and stabilization of ibuprofen nanoparticles in supercritical fluid processing,” "J. Supercrit. Fluids |
|
| [2] D. Kayrak, U. Akman, and ệ. Hortaỗsu, “Micronization of Ibuprofen by RESS,” J. Supercrit. Fluids, vol. 26, no. 1, pp. 17–31, 2003 |
Sách, tạp chí |
| Tiêu đề: |
Micronization of Ibuprofen by RESS,” "J. "Supercrit. Fluids |
|
| [3] K. Vasukumar and A. K. Bansel, “Supercritical fluids technology in pharmaceutical research,” Curr. Res. Inf. Pharm. Sci., vol. 2, pp. 8–12, 2003 |
Sách, tạp chí |
| Tiêu đề: |
Supercritical fluids technology in pharmaceutical research,” "Curr. Res. Inf. Pharm. Sci |
|
| [4] M. Perrut, J. Jung, and F. Lebpeuf, “Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I. Micronization of neat particles,”Int. J. Pharm., vol. 288, pp. 3–10, 2005 |
Sách, tạp chí |
| Tiêu đề: |
Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I. Micronization of neat particles,” "Int. J. Pharm |
|
| [5] Y. Tozuka, Y. Miazaki, and H. Takeuchi, “A combinational supercritical CO2 system for nanoparticle preparation of indomethacin,” Int. J. Pharm., vol. 386, pp. 243–248, 2010 |
Sách, tạp chí |
| Tiêu đề: |
A combinational supercritical CO2 system for nanoparticle preparation of indomethacin,” "Int. J. Pharm |
|
| [6] G. Charbit, E. Badens, and O. Boutin, “Methods of particle formation,” in Supercritical Fluid Technology for Drug Product Development, New York: Marcel Dekker Inc., 2004, pp. 159–161 |
Sách, tạp chí |
| Tiêu đề: |
Methods of particle formation,” in "Supercritical Fluid Technology for Drug Product Development |
|
| [7] C. Atila, N. Yıldız, and A. Çalımlı, “Particle size design of digitoxin in supercritical fluids,” J. Supercrit. Fluids, vol. 51, no. 3, pp. 404–411, 2010 |
Sách, tạp chí |
| Tiêu đề: |
Particle size design of digitoxin in supercritical fluids,” "J. Supercrit. Fluids |
|
| [8] J. Jung and M. Perrut, “Particle design using supercritical fluids: Literature and patent survey,” J. Supercrit. Fluids, vol. 20, no. 3, pp. 179–219, Aug. 2001 |
Sách, tạp chí |
| Tiêu đề: |
Particle design using supercritical fluids: Literature and patent survey,” "J. Supercrit. Fluids |
|
| [9] R. O. Williams III, W. B. Alan, and M. A. Dave, Eds., Formulating Poorly Water Soluble Drugs. London: Springer, 2012 |
Sách, tạp chí |
| Tiêu đề: |
Formulating Poorly Water Soluble Drugs |
|
| [10] C. Lipinski, “Poor aqueous solubility: an industry wide problem in drug discovery,” Am. Pharm. Rev., vol. 5, pp. 82–85, 2002 |
Sách, tạp chí |
| Tiêu đề: |
Poor aqueous solubility: an industry wide problem in drug discovery,” "Am. "Pharm. Rev |
|
| [11] M. Pourasghar, S. Fatemi, A. Vatanara, and R. A. Najafabadi, “Production of ultrafine drug particles through rapid expansion of supercritical solution; a statistical approach,”Powder Technol., vol. 225, pp. 21–26, 2012 |
Sách, tạp chí |
| Tiêu đề: |
Production of ultrafine drug particles through rapid expansion of supercritical solution; a statistical approach,” "Powder Technol |
|
| [12] P. York, U. B. Kompella, and B. Y. Shekunov, Supercritical Fluid Technology for Drug Product Development. New York: Marcel-Dekker, 2004 |
Sách, tạp chí |
| Tiêu đề: |
Supercritical Fluid Technology for Drug Product Development |
|
| [13] “Nanotechnology,” 2013. [Online]. Available: http://people.bath.ac.uk/acb40/DreamweaverWebsite/nanometrologyandnanomanufacturing.html |
Sách, tạp chí |
|
| [14] R. H. Müller, C. Jacobs, and O. Kayser, “Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future,”Adv. Drug Deliv. Rev., vol. 47, pp. 3–19, 2001 |
Sách, tạp chí |
| Tiêu đề: |
Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future,” "Adv. Drug Deliv. Rev |
|
| [15] R. H. Müller, M. Radtke, and S. A. Wissing, “Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations,” Adv.Drug Deliv. Rev., vol. 54 (Supple, pp. S131–S155, 2002 |
Sách, tạp chí |
| Tiêu đề: |
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations,” "Adv. "Drug Deliv. Rev |
|
| [16] S. A. Wissing, O. Kayser, and R. H. Müller, “Solid lipid nanoparticles for parenteral drug delivery,” Adv. Drug Deliv. Rev., vol. 56, pp. 1257–1272, 2004 |
Sách, tạp chí |
| Tiêu đề: |
Solid lipid nanoparticles for parenteral drug delivery,” "Adv. Drug Deliv. Rev |
|
| [17] C. M. Keck and R. H. Müller, “Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation,” Eur. J. Pharm. Biopharm., vol. 62, pp. 3–16, 2006 |
Sách, tạp chí |
| Tiêu đề: |
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation,” "Eur. J. Pharm. Biopharm |
|
| [18] K. Keck, S. Kobierski, R. Mauludin, and R. H. Müller, “Second generation of drug nanocrystals for delivery of poorly soluble drugs: smart Crystals technology,” Eur. J.Pharm. Biopharm., vol. 24, pp. 124–128, 2008 |
Sách, tạp chí |
| Tiêu đề: |
Second generation of drug nanocrystals for delivery of poorly soluble drugs: smart Crystals technology,” "Eur. J. "Pharm. Biopharm |
|
| [19] R. Shegokar and R. H. Müller, “Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives,” Int. J. Pharm., vol. 399, pp. 129–139, 2010 |
Sách, tạp chí |
| Tiêu đề: |
Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives,” "Int. J. Pharm |
|
| [20] J. F. Bishop, K. C. Cundy, D. A. Czekai, and G. G. Liversidge, “Surface modified drug nanoparticles,” 51456841992 |
Sách, tạp chí |
| Tiêu đề: |
Surface modified drug nanoparticles |
|